Cover Image

A narrative review of meal management with the MiniMed ™ 780G system: Evolution of dietary management in type 1 diabetes

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Shannon Edd, Maya Laron‐Hirsch, Javier Castañeda, Tim van den Heuvel, Goran Petrovski, Ohad Cohen
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Diabetes, Obesity and Metabolism
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Challenges in glycaemic control among women with type 1 diabetes and the role of MiniMed 780G system: A narrative review
by: Isabeau Thijs, et al.
Published: (2026)

Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
by: Yongwen Zhou, et al.
Published: (2025)

Performance of the MiniMed 780 G system on mitigating menstrual cycle‐dependent glycaemic variability
by: Yasmine Ibrahim Elhenawy, et al.
Published: (2024)

Generating real‐world evidence on diabetes technology using the CareLink Personal data management system
by: Tim van den Heuvel, et al.
Published: (2024)

Discordant real‐world glycaemic outcomes with Omnipod™ 5 and MiniMed™ 780G in adults with type 1 diabetes: Why validated measures matter
by: Panagiotis Pavlou, et al.
Published: (2026)

Is low‐dose glucagon needed and effective in preventing fasted exercise‐induced hypoglycaemia in type 1 diabetes treated with the MiniMed 780G , an automated insulin delivery system?
by: Sissel Banner Lundemose, et al.
Published: (2024)

Comment to ‘Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—“ eCGM ”’
by: Ohad Cohen, et al.
Published: (2025)

What is the impact of an advanced hybrid closed‐loop system on weight control among people with type 1 diabetes?
by: Sarah Koning, et al.
Published: (2025)

Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review
by: Alice Y. Y. Cheng, et al.
Published: (2025)

The role of real‐time continuous glucose monitoring in diabetes management and how it should link to integrated personalized diabetes management
by: Monika Reddy, et al.
Published: (2024)

Practical strategies to manage obesity in type 2 diabetes
by: Helena W. Rodbard, et al.
Published: (2024)

Impact of an online nutrition management application service on glycaemic management in individuals with diabetes: A propensity‐score‐matched retrospective cohort study
by: Junya Hironaka, et al.
Published: (2024)

Economic burden of type 2 diabetes management in France according to clinical characteristics
by: Bruno Guerci, et al.
Published: (2026)

Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff model
by: Phil McEwan, et al.
Published: (2025)

Association between diabetes self‐management education attendance, hospital admissions and mortality in type 2 diabetes: A cohort analysis protocol
by: Gemma A. Lewis, et al.
Published: (2025)

A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies
by: Alexandra Katz, et al.
Published: (2026)

Association between daily steps, diabetes management and health indicators in people living with type 1 diabetes: A cross‐sectional study from the BETTER registry
by: Thélo I. Garré, et al.
Published: (2026)

Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts
by: Gian Paolo Fadini, et al.
Published: (2024)

An overview of the CANVAS Program and CREDENCE trial: The primary outcomes and key clinical implications for those managing patients with type 2 diabetes
by: Angela X. Chen, et al.
Published: (2024)

Metformin monotherapy versus predominantly older non‐metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes management
by: Mingyang Sun, et al.
Published: (2024)

Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER ‐2 trial emulation with real‐world data
by: Gian Paolo Fadini, et al.
Published: (2025)

Predictors of diabetic ketoacidosis in patients with insulin‐deficient diabetes phenotype initiating SGLT2 inhibitors
by: Anat Tsur, et al.
Published: (2025)

Longitudinal trajectories of fasting plasma glucose predicting cardiovascular disease risk in Chinese patients with type 2 diabetes under health management
by: Shijun Liu, et al.
Published: (2025)

A predictive model for medium‐term weight loss response in people with type 2 diabetes engaging in behavioural weight management interventions
by: Lulwa Al‐Abdullah, et al.
Published: (2024)

Potential benefits of hybrid closed‐loop systems for managing moderate‐ to high‐risk individuals with type 1 diabetes during Ramadan fasting
by: Abdullah M. Alguwaihes, et al.
Published: (2025)

Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials
by: Kitti Thammakosol, et al.
Published: (2025)

Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol
by: Ivana Rabbone, et al.
Published: (2025)

Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
by: Irl B. Hirsch, et al.
Published: (2024)

Correction to ‘Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials’
Published: (2026)

Partial non‐adherence to antidiabetic therapy undermines diabetes management and correlates with treatment complexity: A cross‐sectional study using blood plasma analysis
by: Vojtěch Škop, et al.
Published: (2025)

Real‐world effectiveness of sodium‐glucose cotransporter‐2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria
by: Afif Nakhleh, et al.
Published: (2024)

The challenge of assessing impaired awareness of hypoglycaemia in diabetes in the era of continuous glucose monitoring: A narrative review of evidence and translation into clinical practice
by: Simon A. Berry, et al.
Published: (2025)

Trends in pharmacological management of paediatric patients with type 2 diabetes from 2000 to 2023 in German‐speaking countries: Analysis based on the Diabetes Prospective Follow‐up Registry
by: Susanna Wiegand, et al.
Published: (2024)

Comment on “Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes”
by: Manish R. Bhise, et al.
Published: (2025)

Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective
by: Stefano Del Prato, et al.
Published: (2024)

Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis
by: Satish K. Garg, et al.
Published: (2024)

Optimising the CamAPS FX automated insulin delivery system for exercise and complex meals in adolescents with type 1 diabetes: A prospective interventional study in a camp setting
by: Andrea E. Scaramuzza, et al.
Published: (2025)

The melanocortin‐4 receptor pathway and the emergence of precision medicine in obesity management
by: Sima Fansa, et al.
Published: (2024)

The Goldilocks for chronic weight management—Balancing quantity with quality of weight loss
by: Kim Henriksen, et al.
Published: (2025)

Spillover effects of a nudge‐based dietary intervention on physical activity and sleep among adults with type 2 diabetes: Evidence from a randomised controlled trial
by: Xiaojing Guo, et al.
Published: (2026)